These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 6764980)

  • 1. [Reactogenicity and immunogenic activity of live influenza vaccines made from recombinant viruses].
    Vasil'eva RI; Koliakh LI; Rumel' NB; Erofeeva MK; Maksakova VL
    Tr Inst Im Pastera; 1982; 58():19-22. PubMed ID: 6764980
    [No Abstract]   [Full Text] [Related]  

  • 2. Vaccination activity of live influenza vaccine in different seasons of the year.
    Zykov MP; Sosunov AV
    J Hyg Epidemiol Microbiol Immunol; 1987; 31(4):453-9. PubMed ID: 3429857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subunit influenza vaccine and its testing in clinical immunology.
    Zykov MP; Rudenko LG; Zoshchenkova NY; Rafael'skaya TI
    J Hyg Epidemiol Microbiol Immunol; 1980; 24(2):212-8. PubMed ID: 6997374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunogenic study of killed influenza vaccine purified and concentrated by a chromatographic method on silica sorbents. II. The immunogenic properties of a vaccine from the A/Scotland/74 strain].
    Polzik TP; Bichurina MA; Goriunova VV; Bokhnevich GM; Polianskaia NIu
    Tr Inst Im Pastera; 1976; 47():128-33. PubMed ID: 210538
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effectiveness of inactivated vaccines against influenza].
    Fridman EA; Peradze TV
    Tr Inst Im Pastera; 1982; 58():84-94. PubMed ID: 6764983
    [No Abstract]   [Full Text] [Related]  

  • 6. [An immunogenicity and reactogenicity study of a purified, inactivated trivalent influenza vaccine for parenteral administration prepared for the 1996-1997 season].
    Lupulescu E; Ioniţă E; Botez D; Matepciuc M; Tabra ME; Tecu C; Alexandrescu V; Munţiu A
    Bacteriol Virusol Parazitol Epidemiol; 1997; 42(1-2):110-2. PubMed ID: 9235136
    [No Abstract]   [Full Text] [Related]  

  • 7. [Vaccinal prevention of influenza in children].
    Zykov MP; Vasil'eva RI
    Tr Inst Im Pastera; 1982; 58():30-8. PubMed ID: 6764981
    [No Abstract]   [Full Text] [Related]  

  • 8. [Reactogenic properties and the immunological activity of an absorbed influenza chemical vaccine].
    Rudenko LG; Ishkil'din MI; Esorov PA; Ranevskiĭ VD; Zoshchenkova PIa
    Tr Inst Im Pastera; 1976; 47():160-3. PubMed ID: 802568
    [No Abstract]   [Full Text] [Related]  

  • 9. Inactivated influenza A/New Jersey/76 vaccines in children: results of a mult-center trial.
    Wright PF; Vaughn WK; Thompson J; Sell SH; Karzon DT
    Dev Biol Stand; 1977 Jun 1-3; 39():309-13. PubMed ID: 342312
    [No Abstract]   [Full Text] [Related]  

  • 10. [Characteristics of the reproductive and immunogenic activity of moderately attenuated influenza A/1977-1980 viruses].
    Zhilova GP; Ermolaeva OM; Orlov VA
    Tr Inst Im Pastera; 1982; 58():25-30. PubMed ID: 7187550
    [No Abstract]   [Full Text] [Related]  

  • 11. [Further study of the reactogenic properties and safety of a killed influenza A/Scotland/74 vaccine].
    Ranevskiĭ VD; Belov AB; Ivanov KG; Ishkil'din MI; Markelov IM
    Tr Inst Im Pastera; 1976; 47():121-3. PubMed ID: 802564
    [No Abstract]   [Full Text] [Related]  

  • 12. Safety, reactogenicity and immunogenicity of Madin Darby Canine Kidney cell-derived inactivated influenza subunit vaccine. A meta-analysis of clinical studies.
    Palache AM; Scheepers HS; de Regt V; van Ewijk P; Baljet M; Brands R; van Scharrenburg GJ
    Dev Biol Stand; 1999; 98():115-25; discussion 133-4. PubMed ID: 10494964
    [No Abstract]   [Full Text] [Related]  

  • 13. Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age.
    Block SL; Yogev R; Hayden FG; Ambrose CS; Zeng W; Walker RE
    Vaccine; 2008 Sep; 26(38):4940-6. PubMed ID: 18662737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vaccination against influenza in the elderly. Experience with adjuvant vaccines].
    Baldo V; Menegon T; Buoro S; Scalici C; Vesco A; Perale S; Boato W; Carletti M; Bonello C; Dalla Costa D; Trivello R
    Ann Ig; 1999; 11(5):369-74. PubMed ID: 10596424
    [No Abstract]   [Full Text] [Related]  

  • 15. [Properties and biological activity of inactivated influenza vaccine].
    D'iachenko AP
    Mikrobiol Zh (1978); 1982; 44(3):57-9. PubMed ID: 7121321
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antibody formation and preservation against the envelope antigens of influenza virus subtype A(H3N2) after infection and vaccination].
    Stumpa A; Tůmová B
    Tr Inst Im Pastera; 1982; 59():23-8. PubMed ID: 6764986
    [No Abstract]   [Full Text] [Related]  

  • 17. Attenuated influenza A viruses with modified cleavage sites in hemagglutinin as live vaccines.
    Stech J
    Expert Rev Vaccines; 2008 Aug; 7(6):739-43. PubMed ID: 18665773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal DNA vaccine for influenza is immunogenic in humans.
    Drape RJ; Macklin MD; Barr LJ; Jones S; Haynes JR; Dean HJ
    Vaccine; 2006 May; 24(21):4475-81. PubMed ID: 16150518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Safety and immunogenicity of split vaccines of influenza viruses].
    Zhu CL; Fang HH; Zhu FC; Wang YQ; Wu XL; Xue FB; Shen YJ; Lian JZ
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Sep; 18(3):207-9. PubMed ID: 15640848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation and evaluation of the trivalent inactivated reassortant vaccine using human, avian, and swine influenza A viruses.
    Du N; Li W; Li Y; Liu S; Sui Y; Qu Z; Wang Y; Du Y; Xu B
    Vaccine; 2008 Jun; 26(23):2912-8. PubMed ID: 18448208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.